Publication | Closed Access

Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial

Second-line TreatmentThrombosisThrombopoiesisHematological MalignancyOncologyHealth SciencesPrimary Immune ThrombocytopeniaImmunologyClinical TrialsHematologyPharmacotherapyImmunotherapyMedicineDanazol Versus Danazol